JP2021514207A5 - - Google Patents
Info
- Publication number
- JP2021514207A5 JP2021514207A5 JP2020566878A JP2020566878A JP2021514207A5 JP 2021514207 A5 JP2021514207 A5 JP 2021514207A5 JP 2020566878 A JP2020566878 A JP 2020566878A JP 2020566878 A JP2020566878 A JP 2020566878A JP 2021514207 A5 JP2021514207 A5 JP 2021514207A5
- Authority
- JP
- Japan
- Prior art keywords
- modified
- viral
- viral vector
- neurons
- gene
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024014824A JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18156932.8 | 2018-02-15 | ||
| EP18156932 | 2018-02-15 | ||
| PCT/EP2019/053610 WO2019158619A1 (en) | 2018-02-15 | 2019-02-14 | Modified viral capsids |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014824A Division JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021514207A JP2021514207A (ja) | 2021-06-10 |
| JP2021514207A5 true JP2021514207A5 (enExample) | 2022-02-22 |
Family
ID=61521290
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020566878A Pending JP2021514207A (ja) | 2018-02-15 | 2019-02-14 | 改変ウイルスカプシド |
| JP2024014824A Pending JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024014824A Pending JP2024050766A (ja) | 2018-02-15 | 2024-02-02 | 改変ウイルスカプシド |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US20210107947A1 (enExample) |
| EP (1) | EP3752521A1 (enExample) |
| JP (2) | JP2021514207A (enExample) |
| CN (1) | CN112105630A (enExample) |
| AU (2) | AU2019220368B2 (enExample) |
| BR (1) | BR112020016666A2 (enExample) |
| CA (1) | CA3095660A1 (enExample) |
| SG (1) | SG11202009854XA (enExample) |
| WO (1) | WO2019158619A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2023518809A (ja) * | 2020-03-20 | 2023-05-08 | ディグニティー ヘルス | アデノ随伴ウイルスの改変方法及び分離方法 |
| CA3181024A1 (en) | 2020-08-06 | 2022-02-10 | Fundacion Para La Investigacion Medica Aplicada | Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy |
| KR20240095539A (ko) | 2021-10-08 | 2024-06-25 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 변이체 및 이의 사용 방법 |
| CN115894659B (zh) * | 2022-10-19 | 2023-11-10 | 上海优宁维生物科技股份有限公司 | 微管相关蛋白Tau抗原及其制备方法和应用 |
| JP2026509271A (ja) | 2023-03-10 | 2026-03-17 | ダイノ セラピューティクス，インコーポレーテッド | カプシドポリペプチドおよびその使用方法 |
| KR20260082361A (ko) | 2023-08-31 | 2026-06-04 | 디노 테라퓨틱스, 인코포레이티드 | 캡시드 폴리펩타이드 및 이의 사용 방법 |
| WO2025082618A1 (en) | 2023-10-20 | 2025-04-24 | Fuse Vectors Aps | In vitro parvovirus capsid manufacturing |
| TW202545971A (zh) | 2024-02-08 | 2025-12-01 | 美商戴諾治療公司 | 殼體多肽及其使用方法 |
| WO2026064442A2 (en) | 2024-09-18 | 2026-03-26 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
| WO2026122963A1 (en) | 2024-12-06 | 2026-06-11 | Dyno Therapeutics, Inc. | Capsid polypeptides and methods of use thereof |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2003534805A (ja) * | 2000-05-31 | 2003-11-25 | ユニバーシティ オブ サスカチュワン | 変化した親和性を有する改変ウシアデノウイルス |
| SI1496944T1 (sl) * | 2002-05-01 | 2009-02-28 | Univ Florida | Izboljšani sistemi ekspresije RAAV za genetsko modifikacijo specifičnih kapsidnih proteinov |
| EP3049527A4 (en) * | 2013-09-26 | 2017-08-16 | University of Florida Research Foundation, Inc. | Synthetic combinatorial aav capsid library for targeted gene therapy |
| WO2015117010A2 (en) * | 2014-01-31 | 2015-08-06 | Temple University Of The Commonwealth System Of Higher Education | Bag3 as a target for therapy of heart failure |
| WO2016054557A1 (en) * | 2014-10-03 | 2016-04-07 | University Of Massachusetts | Novel high efficiency library-identified aav vectors |
| CA2977355A1 (en) * | 2015-02-20 | 2016-08-25 | University Of Iowa Research Foundation | Methods and compositions for treating genetic eye diseases |
| WO2017192750A1 (en) * | 2016-05-04 | 2017-11-09 | Oregon Health & Science University | Recombinant adeno-associated viral vectors |
| CN109640949B (zh) * | 2016-07-29 | 2022-11-25 | 加利福尼亚大学董事会 | 具有变异衣壳的腺相关病毒病毒体和其使用方法 |
| KR20190075964A (ko) * | 2016-10-13 | 2019-07-01 | 유니버시티 오브 매사추세츠 | Aav 캡시드 설계 |
| US20230048025A1 (en) * | 2016-12-22 | 2023-02-16 | Oregon Health & Science University | Adeno associated viral vectors |
| EP3585883A4 (en) * | 2017-02-21 | 2021-04-14 | University of Florida Research Foundation, Incorporated | MODIFIED AAV CAPSID PROTEINS AND USES THEREOF |
| KR20250023600A (ko) * | 2017-06-30 | 2025-02-18 | 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 | 변이체 캡시드를 보유한 아데노-부속 바이러스 비리온 및 이의 사용 방법 |
-
2019
- 2019-02-14 AU AU2019220368A patent/AU2019220368B2/en active Active
- 2019-02-14 CN CN201980026061.6A patent/CN112105630A/zh active Pending
- 2019-02-14 WO PCT/EP2019/053610 patent/WO2019158619A1/en not_active Ceased
- 2019-02-14 BR BR112020016666-9A patent/BR112020016666A2/pt not_active Application Discontinuation
- 2019-02-14 EP EP19703748.4A patent/EP3752521A1/en active Pending
- 2019-02-14 SG SG11202009854XA patent/SG11202009854XA/en unknown
- 2019-02-14 JP JP2020566878A patent/JP2021514207A/ja active Pending
- 2019-02-14 US US16/970,004 patent/US20210107947A1/en not_active Abandoned
- 2019-02-14 CA CA3095660A patent/CA3095660A1/en active Pending
-
2024
- 2024-02-02 JP JP2024014824A patent/JP2024050766A/ja active Pending
- 2024-07-01 AU AU2024204557A patent/AU2024204557A1/en active Pending
- 2024-08-13 US US18/802,552 patent/US20250051396A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7433360B2 (ja) | Ｐａｈ遺伝子移入のためのアデノ随伴ウイルス組成物及びそれらの使用方法 | |
| CN115023242B (zh) | 腺相关病毒载体变体 | |
| Löw et al. | Direct and retrograde transduction of nigral neurons with AAV6, 8, and 9 and intraneuronal persistence of viral particles | |
| JP2023525810A5 (enExample) | ||
| Bowers et al. | Genetic therapy for the nervous system | |
| AU2019220368B2 (en) | Modified viral capsids | |
| US11472859B2 (en) | Method and composition for treating neuronal hyper-excitabtiity | |
| CN113121655B (zh) | 眼部和肌肉特异靶向型腺相关病毒载体及其应用 | |
| US9486540B2 (en) | Methods for delivery to the central nervous system of nucleic acid nanoparticles to treat central nervous system disorders | |
| CN121488045A (zh) | Aav衣壳变体及其用途 | |
| US20220106613A1 (en) | Neurod1 vector | |
| Li et al. | An overview of the therapeutic strategies for the treatment of spinal muscular atrophy | |
| US20200318080A1 (en) | Methods and compositions for treating equine conditions using recombinant self-complementary adeno-associated virus | |
| US20220098254A1 (en) | NEUROD1 and DLX2 VECTOR | |
| US20220098255A1 (en) | Neurod1 combination vector | |
| Meng et al. | Specific gene expression in mouse cortical astrocytes is mediated by a 1740bp-GFAP promoter-driven combined adeno-associated virus2/5/7/8/9 | |
| Kullmann | Recent progress and challenges in gene therapy for pharmacoresistant focal epilepsy | |
| US20210283222A1 (en) | Methods and compositions for treating canine conditions using recombinant self-complementary adeno-associated virus | |
| Verkuyl et al. | Toward an all-in-one recombinant adeno-associated virus vector for functionally ablating the prion gene using CRISPR-Cas technology | |
| CN118613590A (zh) | 用于玻璃体内施用的功能性aav衣壳 | |
| JP2023543360A (ja) | Ｄｌｘ２ベクター | |
| CN111093716A (zh) | 用于治疗神经性疼痛的方法和组合物 | |
| EP4705490A1 (en) | Capsids and methods of targeting nuerons | |
| CN116761812A (zh) | Neurod1和dlx2载体 | |
| WO2025125692A1 (en) | Viral vector for transduction of adipocytes |